ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000808.1|Cepacian_1 # 1 # 1167 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.711	BGC0000808.1|Cepacian_1 	1	1167	-	Loose	700	52.7582	LpsB	23.61	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGTCCTCTTCTTCCCGGCCGATCAAATCGCTGCAGATCGGCATGCACTGGTTTCCCGAACGCGCGGGCGGCCTCGACCGCATGTATTACTCGCTCGTCGGCGCGCTGCCCGGCGCGGGCGTCGAGGTGCGCGGGCTCGTCGCCGGCTCGCCGAAGGTCGCCGACGACACGGGCGGTGCGATCCAGGGCTTCGGCCCCGCGTCGCAGCCGCTCGCGCGCCGGATGCTCGCCGCGCGGCGCGCGCTGCGCGACGAGATCCGCAGCGCGCGGCCCGACGTGATCTCGTCGCACTTCGCGCTCTATACGTTTCCGGGGCTCGACGTGACGCGCGGGATTCCGCAGGTGTCGCACTTTCAGGGGCCGTGGGCCGACGAGAGCCAGGTCGAGGGCGCCGCGTCGCTCGGCCAGCGCGCGAAGCGCTATCTCGAACAGGCCGTGTATGCGCGTTCGTCGCGGCTGATCGTGCTGTCGCAGGCGTTCGGCCAGATCCTCACGCAACGCTACGGGATCGATCCGTCGCGCGTGCGCGTGATTCCCGGCTGCGTCGACACCGCGCAGTTCGACACGCCGCTCACGCCGGCCGAGGCACGGCAGCGGCTGCAACTGCCGCAGGATCGGCCGATCGTGCTCGCGGTGCGTCGTCTCGTGCGGCGGATGGGGCTCGAGGATCTCGTCGACGCGATCGGGATCGTGAAGCGCCGCCATCCGGACGTGCTTCTGCTGATCGCCGGCAAGGGCAAGCTTGCCGAGGAGCTGCAGCAGCGCATCGACGCGGCCGGGCTGCAGGACAACGTGAAGCTGCTCGGCTTCGTGCCCGATCAGCATCTCGCGGCGCTCTATCGCGCGGCAACGGTCAGCGTCGTGCCGACCGTCGCGCTCGAGGGCTTCGGGCTCATCACGGTCGAATCGCTCGCGTCCGGCACGCCGGTGCTCGTGACGCCGGTGGGCGGCCTGCCCGAGGCGGTGGCCGGGTTGTCGAGCGACCTCGTGCTGCCGTCGACGGGCGCCGACGCGATTGCCGAAGGGCTCGGCGCCGCGCTGTCGGGCGCGATTGCGTTGCCCGACGAGGCCGCGTGCAAGCGCTATGCGCGTGAGCATTTCGACAACGCGGTGATCGCGCGACGCGTCGCCGGCGTGTACGAGGAGGCGATCCACGCGGCGGGCTGA	MSSSSRPIKSLQIGMHWFPERAGGLDRMYYSLVGALPGAGVEVRGLVAGSPKVADDTGGAIQGFGPASQPLARRMLAARRALRDEIRSARPDVISSHFALYTFPGLDVTRGIPQVSHFQGPWADESQVEGAASLGQRAKRYLEQAVYARSSRLIVLSQAFGQILTQRYGIDPSRVRVIPGCVDTAQFDTPLTPAEARQRLQLPQDRPIVLAVRRLVRRMGLEDLVDAIGIVKRRHPDVLLLIAGKGKLAEELQQRIDAAGLQDNVKLLGFVPDQHLAALYRAATVSVVPTVALEGFGLITVESLASGTPVLVTPVGGLPEAVAGLSSDLVLPSTGADAIAEGLGAALSGAIALPDEAACKRYAREHFDNAVIARRVAGVYEEAIHAAG	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	106.01	gnl|BL_ORD_ID|2781|hsp_num:0	3793			9	990	colistin A; colistin B; defensin
BGC0000808.1|Cepacian_2 # 1167 # 2351 # -1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0000808.1|Cepacian_2 	1167	2351	-	Loose	700	32.7278	LpsB	22.69	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	TTGAGAATCGCGATCGTCACGCACGTCGTGCGTCATAACGACGGCCAGGGCCGCGTCAATTACGAAATCGCGCGCGCGGCGCTGGCCGAACAATGCGAGGTCACGCTCGTCGCGTCGCACGTCGCGCCGGAGCTGCTCGCCGATCCGCGCGTGCGCTGGGTGCCCGTGAAAGTCGGGCGCTTCTGGCCGTCGAATCTCGTGCGGCAGCAGGTGTTCGCGCTGAAGAGCGCGTGGTGGCTGCGCACGCATCGCGACGCGTACGACGTGCTGCACGTGAACGGCTTCATCTCGTGGATCAAGGCCGACGTGAACACCGCGCACTTCGTGCACGGCGGCTGGTTCAAGAGCCCGTACTATCCGTTCGCGCTGACCAAAGGGCTGTGGTCCGCGTACCAGTACGTGTACACGCGCGTGAATACCGCGCTCGAGCGCTGGGCGTACCGGCGTTCGCGCGCGATCACCGCGGTGTCGCAGAAGGTCGCCGACGAAATCGCGGCGCTCGGCATCGACCGCAGCAAGATCGGCGTCATCTACAACGGCGTCGACGGCAGCGCGTTCGCCGGCGCACAAGCGGACCGCGCGGCGTTCGATCTGCCGCCCGATGCGTTCCTGCTGCTGTTCGTCGGCGATCTGCGCACGCCGCGCAAGAACCTCGGCACCGTGCTGAAGGCGCTGACGAAGCTGCCGGAACACGTGCATCTCGCGGTCGCCGGCTATCTGCCCGGCAGCCCCTATCCGGACGAGGCGCGCGCGCTCGGCCTCGGCGCACGCGTGCACTTCCTCGGTCTCGTCAAGAACATGCCGACGCTGATGCGCTCGGTCGACGCGTACGTGTTTCCGTCGCGCTACGAAGCGATGAGCCTGTCGCTGCTCGAAGCGATGGCGGCCGGGCTGCCCGTCGTCACCGCGCGCACCGCGGGCGGCGCCGAGATCATCACGCGCGACTGCGGGATCGTGCTCGACGATCCGGACGATCCGGACGCGCTCGCGCAGGCGATCGACCTGCTCGCAGCGTCGCGCGACACGTGCCGCGCGATGGGCGCGGCCGCGCGCGAACTGATGACCCGTTTCGGCTGGGCCCACATGGGCGCCCAGTACGTTGCGCTGTACCGGCGCATCGGCCAACCTCCGCAGCCGTCCGCGTTCGCGCGCGTCGAGCATGCGGTCACGCAGGAGCAATCGTGA	MRIAIVTHVVRHNDGQGRVNYEIARAALAEQCEVTLVASHVAPELLADPRVRWVPVKVGRFWPSNLVRQQVFALKSAWWLRTHRDAYDVLHVNGFISWIKADVNTAHFVHGGWFKSPYYPFALTKGLWSAYQYVYTRVNTALERWAYRRSRAITAVSQKVADEIAALGIDRSKIGVIYNGVDGSAFAGAQADRAAFDLPPDAFLLLFVGDLRTPRKNLGTVLKALTKLPEHVHLAVAGYLPGSPYPDEARALGLGARVHFLGLVKNMPTLMRSVDAYVFPSRYEAMSLSLLEAMAAGLPVVTARTAGGAEIITRDCGIVLDDPDDPDALAQAIDLLAASRDTCRAMGAAARELMTRFGWAHMGAQYVALYRRIGQPPQPSAFARVEHAVTQEQS	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	107.65	gnl|BL_ORD_ID|2781|hsp_num:0	3793			474	1092	colistin A; colistin B; defensin
BGC0000808.1|Cepacian_3 # 2348 # 3814 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.669	BGC0000808.1|Cepacian_3 	2348	3814	-	Loose	500	30.0314	bcr-1	45.45	3003801	protein homolog model	n/a	n/a	bicyclomycin-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCACGCTTGCCGCCGAACACGCGCCGGCGCGCAAGCGCAGCCGGTTCGCCGAGCCGACGCAGTGGGCCGGCCAGGCCGCGCTGTGGACGATCACGGCCGCGCTGATCGCCGCGCATCAGGGACGCGTGCTGACGTTCGCGTTTCCGGTGCTCGCGATCGCCGTCGGCATCTGGCTGTACTTCAAGAGCCCGGCGCGCTACGTCGGCTTCATGTGGTGGGTGTGGTTCCTGAGCCCCGAGGTGCGGCGGCTTGCCGACTGGTCGAAAGGCGCCTTCACGCCGACGAGCCTGATCCAGGTCGCGCCGCTCGCCGTGACGATGATCGCCGCCTTCGGGCTGCTGCGGCATTACCGCGTGCTCGCGCAGCGGCGCGGGATTCCGGTGCTGCTGATCCTGTTCGGACTGACCTACGCCTATCTCGTCGGCATCGTGTCGAGCGGCCTGATGGCCGCGACCTACGACCTCGCGAACTGGCTGTATCCGGTGCTGATCGGCTTTCACATCATGGTCAACGCGCGCAACTATCCGGCGTACCGCGACGTGCTGCTGTCGACCTTCATCTGGGGCATGCTCGTGATGGGCGTGTACGGCATTGTCCAGTACTTCGTGATGCCGCAGTGGGACGTGCTGTGGATGGTCGGCTCGCAAATGGGCTCGCAGGGCGAGCCCGTGCCGTACGGTGTGCGCGTGTTCAGCACGATGAATTCGTCGGGGCCGTTCGCATTCGCGATGATGGGCGCGCTCGTATTCGTGCTGGTCGCGCCGCAGAAGATCCGCTGGTTCGCGGGCGCGGCCGGCTTCGTGTCGTTCGCGCTCTGTCTCGTGCGTTCGACGTGGGGCGGCTGGGTGATCGCGCTCGCGATCCAGCTCGTGCAGTCGAGCAACCGCGTGCGGATGCGGATCCTCATCAGCGGCGTCGTGCTGGTCGGCCTCTGCGTGCCGCTGCTGACCGTCGGGCCCGTCGCCGATCGTCTCGGCCAGCGTCTGCAGTCGATCGTGAACCTGAAGGACGACCGCAGCTACGACGATCGCAACAAGTTCTACGCGACCTTCGCGGAAACCGCGTTCACCGACGTCGCCGGCGAAGGGATGGGCGCGACGGGCGCGTCGACGAAGCTGTCGAGCGACAGCGGCGAACTCGGCAAGTACGGCAGCTTCGACAGCGGCGTGATGAACGTGCCGTTCGTGCTCGGCTGGCCCGGCACGCTGCTCTATCTCGCGGGCTTCGTGATGCTGCTCGGCCGCACGGTGCGCGCGTCGTTCAGGCTGCGCGACGACAAGTTCGTCGGCGCCTGCCTGAGCCTGTGCCTGTCGGTCTTCGCGATGCTCGTGTTCACGAACTCGCTGATCGGCACGGGCGGCCTGCTGTTGTTTACCGCCATTTTTTCGATTCTTTCCGCGGCGCACTGGCAGAGGCTTCAGCGTCTGCCGGCCGCCGCGCGTTTACGGGGAGACGACCATTGA	MSTLAAEHAPARKRSRFAEPTQWAGQAALWTITAALIAAHQGRVLTFAFPVLAIAVGIWLYFKSPARYVGFMWWVWFLSPEVRRLADWSKGAFTPTSLIQVAPLAVTMIAAFGLLRHYRVLAQRRGIPVLLILFGLTYAYLVGIVSSGLMAATYDLANWLYPVLIGFHIMVNARNYPAYRDVLLSTFIWGMLVMGVYGIVQYFVMPQWDVLWMVGSQMGSQGEPVPYGVRVFSTMNSSGPFAFAMMGALVFVLVAPQKIRWFAGAAGFVSFALCLVRSTWGGWVIALAIQLVQSSNRVRMRILISGVVLVGLCVPLLTVGPVADRLGQRLQSIVNLKDDRSYDDRNKFYATFAETAFTDVAGEGMGATGASTKLSSDSGELGKYGSFDSGVMNVPFVLGWPGTLLYLAGFVMLLGRTVRASFRLRDDKFVGACLSLCLSVFAMLVFTNSLIGTGGLLLFTAIFSILSAAHWQRLQRLPAAARLRGDDH	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	121.39	gnl|BL_ORD_ID|2332|hsp_num:0	2303			120	243	bicyclomycin
BGC0000808.1|Cepacian_4 # 3811 # 4950 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0000808.1|Cepacian_4 	3811	4950	-	Loose	650	31.187	tet(X1)	40.0	3005166	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACCGCCACCAAGGTCCACGTGCATCTGTTTTACGGCGCCGATCCGCGTACTTACCGGAAAGGCGACAACATCGGCTGTCTGTACGGCTATCACCACGCGGAATCGGACGAATTCCGGCTCACGTATTCGGCCGACCGGCGCGAGCCGCGCGTGGTCGGCATCGCGCGCCGCGCGCTGAAGGCCGCGCTCGGTTTCGACATCGTGCACGCATGGCGCAACCGCGCGGCGCTGCTGAACGCGGACGTGATCTGGACGCATACCGAGCAGGAGCATCTGGCCGCCGCGCTGATCCTCAAGCTCGCCGGCGCGCAGGGCAAGCGGCCGCTGCTGCTCGCGCAGAGCGTCTGGCTGTTCGACAAATGGCAAAGCTTCGGCGGCCCGCGCCGCTGGCTCTACCGCAAGCTGCTCGCGCGCGCCGACGTGCTGACGACGCTCGCGCGCGACAACGCGGCGCTGTGCCGCCGCTATCTGGGCCGCGACGCGGAGTTCGTCTACTACGGGCTCAACACGCAGGACTTTCCGATCCGCGATCCGCAGCCGTGGCAGCCGCATCGGCCGCTGCGCATCGCGGCGATCGGCAACGATCGCGACCGCGACTGGCGCACGTTTCTCGCCGCGTTCGGCGGCGATGAACGCTACGAGGTGCGGCTCGCGACGCGTCGTCGCGTGCCGCGCGCGTGGCACGCGCCGAACGTCGCGATCGGCTCCGCGTCGGGCCTCGCGAAGCAGCACGAGCTGTACGCGTGGGCCGACGTGATCGTCGTGCCGCTGCGGCCGAACTTCCATGCGTCGGGCATCACCGTGATGCTCGAGGCGGCGGCGCTCGGCAAGCCGATGATCGTGTCCGACGTCGGCGGCCTGACCGACTACTTCCCGCACGACACGGCCGCGTACGTGCCGCCGTTCGACGCGCAGGCGATGCGCGACGCGGCGGATCGCTTCGCGGCCGAGCCGCTCGCGGCGCTCGCCTGCGCGCGCGCCGCCGTCGAGCGGCTGCGTGCGTGCGATCTGACCACGCAGGCGTTCGCGGAGCAGCACGTGCGCATCACGCGCGAGCTGCTGCGCCGGCGCCGCACGCCCGCGGCGGCCGCCGGCGTCGCGATGCCGCTCGCCGATTCCCGGCCGTCGTCGCGATGA	MTATKVHVHLFYGADPRTYRKGDNIGCLYGYHHAESDEFRLTYSADRREPRVVGIARRALKAALGFDIVHAWRNRAALLNADVIWTHTEQEHLAAALILKLAGAQGKRPLLLAQSVWLFDKWQSFGGPRRWLYRKLLARADVLTTLARDNAALCRRYLGRDAEFVYYGLNTQDFPIRDPQPWQPHRPLRIAAIGNDRDRDWRTFLAAFGGDERYEVRLATRRRVPRAWHAPNVAIGSASGLAKQHELYAWADVIVVPLRPNFHASGITVMLEAAALGKPMIVSDVGGLTDYFPHDTAAYVPPFDAQAMRDAADRFAAEPLAALACARAAVERLRACDLTTQAFAEQHVRITRELLRRRRTPAAAAGVAMPLADSRPSSR	MANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEAMKKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKNDTVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFIIQGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKGLDFKPTKSVSEFLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEMRNPSFTFQQLMNV	105.57	gnl|BL_ORD_ID|4803|hsp_num:0	3888			732	846	tetracycline; minocycline; oxytetracycline
BGC0000808.1|Cepacian_5 # 4997 # 6022 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731	BGC0000808.1|Cepacian_5 	4997	6022	-	Loose	600	28.1054	Rm3	30.88	3003894	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	Rm3 family beta-lactamase	ATGAACGCGCTGCACGACACCGGGCCGTCGCGCGATGCGGTCGCCCGGCCGACGGGAGAACCGACCATGAAAATTTCCGTGCTCGTTCCGACCTACCGGCGCCCGGCCGACCTCGCGCGCTGCCTGCTGGCGCTGCAGCGTCAGCAGCGGCTGCCCGACGAGGTGATCGTCGTCGCGCGTCCGGAGGACGACGCCACGCACGAGCGGCTCGCCGATCCGGCGGTCGGCGGCGGGCTGCCGCTGCGGATCGTGCCGGTCGACGTGCCGGGGCAGGTCGCCGCGCTGAACAAGGGCCTCGACACGGCGAGCGGCGACATCGTTGCGATCACCGACGACGATGCGGCGCCGCGCGTCGATTGGCTCGCGCGGATCGAGGCCGCGTTCGCGGCCGATCCGCGCGTCGGCGCGGTCGGCGGACGCGACTGGGTGCACGAGAAGGGCCGCGTGCTCGACGAGTCGCGCGAATGCGTCGGCCGGCTCACGCTGTCCGGCAAGATCATCGGCAACCATCACCTCGGCGTCGGCGGCGCGCGCGAAGTCGACACGCTGAAGGGCGCGAACATGAGCTATCGGCGCGCGGCGATCGCGCGCCTGCGCTTCGACACGCGTCTGCGCGGCGCGGGCGCGCAGACGCACAACGACACCGCGTTCAGCATGGAAGTGCAGCGCGCCGGCTGGAAGCTGATGTACGACCCGGCGATTGCGGTCGATCACTATCCGGCCGAGCGCTTCGACGACGACCGACGCGACGCGGCATCGCTGAACGCGATCGCGAACGGCGCATACAACCTGCAGCTGACGCTGCGCGAGCATCTGCCGCCGCTGCGGCGCGAGATCGCCTGGTGGTGGTGGACGCTCGTCGGCACGCGCGTCTATCCGGGCCTCGCGCATCTGCTGCTCGCACTGCCGACGTCGCGCCGCGCGCGCGTGCTCGCGCACTGGCGCGCCGTGCGCCGCGGCGCGCGCGACGCGCGTCGCACCACCGTTGCCCCGCGCCGTGCGGCGATGCCGCCGGTCACGCCATGA	MNALHDTGPSRDAVARPTGEPTMKISVLVPTYRRPADLARCLLALQRQQRLPDEVIVVARPEDDATHERLADPAVGGGLPLRIVPVDVPGQVAALNKGLDTASGDIVAITDDDAAPRVDWLARIEAAFAADPRVGAVGGRDWVHEKGRVLDESRECVGRLTLSGKIIGNHHLGVGGAREVDTLKGANMSYRRAAIARLRFDTRLRGAGAQTHNDTAFSMEVQRAGWKLMYDPAIAVDHYPAERFDDDRRDAASLNAIANGAYNLQLTLREHLPPLRREIAWWWWTLVGTRVYPGLAHLLLALPTSRRARVLAHWRAVRRGARDARRTTVAPRRAAMPPVTP	MSLTPPRALVLALLLASPGTQAQTPAPATPPTPGCEVCATWNADQAPFRLFGNTYYVGMKGLSSVLVTSPQGHVLIDGGLPESAPKIIANIGALGFRIEDVKLILNSHGHIDHAGGLAELQRRSNALVAASPSAALDLASGEVGPDDPQYHALPKYPPVKDMRLARDGGQFNVGPVYLTAHATPGHTPGGLSWTWQSCDGPRCLNMVYADSINAVSRPGFKFSASSEYPNALADLRHSFETLEKLPCDVLISAHPEASQLWQRLEASATGGSDAFVDPQACRAYVAAARTLLDSRLDQEKQQ	112.91	gnl|BL_ORD_ID|4702|hsp_num:0	2375			630	813	
BGC0000808.1|Cepacian_6 # 6019 # 8244 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000808.1|Cepacian_6 	6019	8244	-	Loose	200	26.9498	vanH gene in vanD cluster	28.4	3002944	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGGTGAACACGCAAGCGAAACACTCCTACGCGGATCCGACCGCGAAGACCGACGAAGAGGACGTCGTCCTCGGCCAGCTGCTGCAGGTGATCCTCGACGACATCTGGCTGCTGCTCGGCATCGCGGTGGCGGTCGTCGCGCTCGCCGGCCTCTACTGCTACGTCGCCAAGCCGGTGTATCAGGCCGACGTGCACGTGCGCGTCGAAGGCAACGACAACACGACGCAGGCGCTCACGCAGACGCAGACCGGCGCGATGATCAACAGCGGCCCGCAGCAGGCGCCGACCGACGCGGAGATCGAGATCATCAAGAGCCGCGGCGTCGTCGCGCCGGTCGTCGAGCAGTTCAAGCTGAACTTCTCGGTCGTGCCGAAGACGATCCCGCTGCTCGGCAGCCTCACGGCGCGGCTCGCGACGCCCGGCGAACCGGCGCGTCCGTGGCTCGGCCTGAAATCGTACGCGTGGGGCGGCGAGGTCGCCGACATCGACTCGATCAACGTCGTGCCCGCGCTCGAAGGCAAGAAGCTGACGCTGACGGCCGGGCCGAACGGCAACTACGTGCTGACCGACGAGAACGGCATGCGGCTGCTGACCGGCCGCGTCGGCGAGTCGGCGCAGGGCGGCGGCGTCACGCTGCTCGTGCAGAAGCTCGTCGCGCGCCCCGGCACGCAGTTTACGGTCACGCGCTACAACGATCTCGACGCGATCACCGGCTTCCAGTCGGGCATCCAGGTGTCCGAGCAGGGCAAGCAGACGGGCGTCGTGCAGATCTCGCTCGAAGGCAAGGATCCGGAGCAGACTGCCGCGATCGCCAACGCGCTCGCGCAGTCGTATCTGCACCAGCACGTGATCGCGAAGCAGGCCGAGGCGACCAAGATGCTCGACTTCCTGAAGGGCGAGGAACCGCGCCTGAAGGCCGATCTCGAACGCGCGGAAGCGGCGCTGACGCAGTATCAGCGCACGTCCGGCTCGATCAACGCGAGCGACGAGGCGAAGGTCTATCTCGAAGGCAGCGTGCAGTACGAACAGCAGATCGCCGCGCAGCGGCTGCAGCTCGCGTCGCTCGCGCAGCGCTTCACCGATTCGCATCCGCTCGTGATCGCCGCGAAGCAGCAGCTCGCGGAGCTGCAGGGCGAGAAGGAGAAATTCAGCAACCGCTTCCGCAGCCTGCCGGCCACCGAAGTGAAGGCCGTGCAGCTGCAGCGCGACGCGAAGGTCGCCGAAGACATCTACGTGCTGCTGCTGAACCGCGTGCAGGAGCTGTCGGTGCAGAAGGCCGGCACGGGCGGCAACATCCATCTGATCGACTCGGCGCTGCGTCCGGGCGCGCCGGTCAAGCCGAAGAAGGTGCTGATCCTGTCGGCCGCGGTGTTCCTCGGGCTGATCCTCGGCACGGGCGTCGTGTTCCTGCGCCGCAACCTGTTCCAGGGGATCGAGGATCCGGACCGCATCGAACGCGCGTTCAACCTGCCGCTCTACGGGCTCGTGCCGCAAAGCGCCGAACAGGCGAAGCTCGACGCGGCGGCCGAGAAGAGCGGCGGCCGTACGCGGCCGATCCTGGCGAGCCTGCGGCCGAAGGATCTCAGCGTCGAAAGCCTGCGCAGCCTGCGCACCGCGATGCAGTTCGCGATGATGGACGCGAAGAACCGCGTGATCGTGCTGACGGGGCCGACGCCCGGCATCGGCAAGAGCTTCCTGACCGTGAACCTCGCGGTGCTGCTCGCGCACTCGGGCAAGCGCGTGCTGCTGATCGACGCCGACATGCGCCGCGGCGTGCTCGACCGCTACTTCGGGCTGACCGCGCAGCCGGGCATGTCGGAACTGCTGAGCGGCCAGTCGGCGCTCGAGGAAGCGGTGCGCGAAACGCCGGTGCAGGGGCTCTCGTTCATCGCGGCCGGCACGCGTCCGCCGAATCCGTCGGAGTTGCTGATGTCGGCGCGTCTGCCGCAATACCTCGAAGGGCTCGGCAAGCGCTACGACGTCGTGCTGATCGATTCGCCGCCGGTGCTCGCGGTGACCGACGCGACGATCATCGGCCGCATGGCGGGCTCGACGTTCCTCGTGCTGCGCTCGGGCATGCATACGGCGGGCGAGATCGCGGACGCGATCAAGCGGCTGCGCACCGCGGGCGTCGATCTCGAAGGCGGGATCTTCAACGGCGTGGCGCCGAAGACGCGCGGCTACGGCCGCGGCTATGCGGCCGTCCACGAATACCTGAGCGCATGA	MVNTQAKHSYADPTAKTDEEDVVLGQLLQVILDDIWLLLGIAVAVVALAGLYCYVAKPVYQADVHVRVEGNDNTTQALTQTQTGAMINSGPQQAPTDAEIEIIKSRGVVAPVVEQFKLNFSVVPKTIPLLGSLTARLATPGEPARPWLGLKSYAWGGEVADIDSINVVPALEGKKLTLTAGPNGNYVLTDENGMRLLTGRVGESAQGGGVTLLVQKLVARPGTQFTVTRYNDLDAITGFQSGIQVSEQGKQTGVVQISLEGKDPEQTAAIANALAQSYLHQHVIAKQAEATKMLDFLKGEEPRLKADLERAEAALTQYQRTSGSINASDEAKVYLEGSVQYEQQIAAQRLQLASLAQRFTDSHPLVIAAKQQLAELQGEKEKFSNRFRSLPATEVKAVQLQRDAKVAEDIYVLLLNRVQELSVQKAGTGGNIHLIDSALRPGAPVKPKKVLILSAAVFLGLILGTGVVFLRRNLFQGIEDPDRIERAFNLPLYGLVPQSAEQAKLDAAAEKSGGRTRPILASLRPKDLSVESLRSLRTAMQFAMMDAKNRVIVLTGPTPGIGKSFLTVNLAVLLAHSGKRVLLIDADMRRGVLDRYFGLTAQPGMSELLSGQSALEEAVRETPVQGLSFIAAGTRPPNPSELLMSARLPQYLEGLGKRYDVVLIDSPPVLAVTDATIIGRMAGSTFLVLRSGMHTAGEIADAIKRLRTAGVDLEGGIFNGVAPKTRGYGRGYAAVHEYLSA	MQEKIDITVFGCERDEAAVFRKLSSEYGVTVSLIEDVVSEHNAKLADGCQCVSVSHKAELSEQLLLALKHAGVKYISTRSIGFNHIDIQAAGQLGMAVGTVAYSPGSVADYTVMLMLMLLRGTKSVLRGTQKQNYCLNDCRGKELQDLTVGVLGTGRIGQAVMERLEGIGCKVLAYDRTHKAGANYVSFCELLKSSDIVTLHVPLAEDTRHMIGREQLEMMKREALLINTARGALVDTAALVAALKEQKIGGAALDVLEGEEGIFYHECTQKTIGHPYLSVLQKMPNVIVTPHTAYHTDRVLVDTVSNTIRNCLNFERSLGNV	229.41	gnl|BL_ORD_ID|1348|hsp_num:0	1333			315	558	vancomycin; teicoplanin
BGC0000808.1|Cepacian_7 # 8310 # 9488 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000808.1|Cepacian_7 	8310	9488	-	Loose	750	25.409	smeD	38.46	3003055	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGAAACGCTCGATGCGCCCGGTGGCGCTTGCCGTCGCGCTGACGACTTTCCTGTCTGCGTGCGCGACCGCCCCCGGCAACTACCTCGACTCGTCGAACCTGAAGGACGACGGCCGGCAGGGCCAGCCCGAGACCTATCCGGTTCATTACATCGACGCCAAGCTCGTGATGGACCAGCTGCAGAAGCAGCAGGTCGAGCATCCGCTGCCGCCGGGCCGCTACACGGATCCGTCGCAGTACGTCTATCACGTCGGCCCGCAGGACATCCTCGGCGTCACCGTGTGGGATCACCCGGAGCTGACGACGCCGCAGGGCCAGTCGTTCTCGAGCGGCGGTAACACGACGCAGACCGTCGCGGGCGCGCTGCAGCAGCCGTATACGAGCGCGCTGCCGGGCCAGGCCGATCCGTACGGGCAGACCGTCGCCGCGGACGGCACGATCTATTTCCCGTTCGTCGGGCGCATCCGCGCGGCCGGCAAGACGGTCGGGCAGATCCGCGACGAGCTGAGTTCGCGCCTCGCGCGTTACGTGAAGAATCCGCAGATCGACGTGCGCGTGCTGTCGTTCCGCAGCCAGAAGGTGCAGGTGACGGGCGAGGTGAAGCAGCCGGGCCCGCTCGCGGTCAGCGACGTGCCGCTGACGCTCGTCGACGCGATCTCGCGCTCGGGCGGCTCGACGGCCGAGGCCGACCTGCAGCGCGTGCGCCTCACGCGCGACGGCAAGCTCTACACGCTCGACGCGAACGGCGTGCTCGACCGCGGCGAAGTGCAGCAGAACGTGATGCTGCAGCCGGGCGACATCATCAACGTGCCGGACCGCAGCGACAGCCGCGTGTTCATCATGGGCGAGGTGAAGACGCCGGTCACGGTGCCGATGCTCAAGGGCCGTCTGACGATCGCCGACGCGCTGACGGCCGGCGGCGGGATTCTCGACACCGACGCGAACCCGCGCAAGATCTACGTGATGCGCGGGATGCGCGACAACCCGACGAAGCCCGAAGTGTTCCGTCTCGACATGACGCAGCCCGACGCGCTGATGCTGTCGAGCCGCTTCCCGCTGCAGCCGCTCGACGTCGTGTACGTGAGCACCGCGGGCTCGGTGCAGTTCAACCGCGTGCTGCAGCAGGTGCTGCCGACGATCCAGACGATCTTCTACATGCGGCAGATCACGCGCTGA	MLKRSMRPVALAVALTTFLSACATAPGNYLDSSNLKDDGRQGQPETYPVHYIDAKLVMDQLQKQQVEHPLPPGRYTDPSQYVYHVGPQDILGVTVWDHPELTTPQGQSFSSGGNTTQTVAGALQQPYTSALPGQADPYGQTVAADGTIYFPFVGRIRAAGKTVGQIRDELSSRLARYVKNPQIDVRVLSFRSQKVQVTGEVKQPGPLAVSDVPLTLVDAISRSGGSTAEADLQRVRLTRDGKLYTLDANGVLDRGEVQQNVMLQPGDIINVPDRSDSRVFIMGEVKTPVTVPMLKGRLTIADALTAGGGILDTDANPRKIYVMRGMRDNPTKPEVFRLDMTQPDALMLSSRFPLQPLDVVYVSTAGSVQFNRVLQQVLPTIQTIFYMRQITR	MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFLVAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARLSAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRIGKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVSILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDAVLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQKIGPGMPVKATEKGDAPAKPAAAAQPAAPAGDAK	99.49	gnl|BL_ORD_ID|255|hsp_num:0	284			0	78	tetracycline; chloramphenicol
BGC0000808.1|Cepacian_8 # 9482 # 9925 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.667	BGC0000808.1|Cepacian_8 	9482	9925	-	Loose	200	23.483	vanT gene in vanN cluster	31.58	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTTCCGGAACATCCTGATCGTCTGTCACGCGAACGTCTGCCGCAGCCCCGCGGCGGAAATGCTGTTCAAGTCGCACGCCGCCTCGCGCGGCGGGCCGCGTGCGACGTTTCATTCGGCTGGCGTTCGCGCGAACGACGGCGACGGCATCGATCCGGTGATGCGGCGGCTGCTCGCCGAGCGCGGCGTCGATGCGACGACGCACCGATCGCGGCGGCTGTCGCGCCGCATCGTGCGCGACGCGGACCTGATCCTCGTCAGCGAGCGTGCGCAGATCGCGGCCGTGGAAGCGATCGACCCGTTCGCGCGCGGCAAGGTTCATCTGCTCGGCAAGTGGGAAGACGCCGAGATCGCCGATCCGCATGGCGGCCCCGAGGCCGACTATCGCGAGAGCTACTCATTGATCGAACGTCTGGTTCAAGGATGGCTGCAAAAACTATGCTGA	MFRNILIVCHANVCRSPAAEMLFKSHAASRGGPRATFHSAGVRANDGDGIDPVMRRLLAERGVDATTHRSRRLSRRIVRDADLILVSERAQIAAVEAIDPFARGKVHLLGKWEDAEIADPHGGPEADYRESYSLIERLVQGWLQKLC	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	21.00	gnl|BL_ORD_ID|4745|hsp_num:0	1983			1086	1257	vancomycin
BGC0000808.1|Cepacian_9 # 9967 # 11379 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.690	BGC0000808.1|Cepacian_9 	9967	11379	-	Loose	700	157.147	ugd	29.49	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAATCTGACTATCATCGGCAGCGGTTACGTAGGTCTGGTCACGGGCGCCTGTCTCGCCGACATCGGCCACGACGTGTTCTGTCTCGACGTCGACCAGGCGAAGATCGACGTGCTCAACGACGGCGGCGTGCCGATCCACGAGCCGGGCCTGAAGGAAGTGATCGCGCGCAACCGCGCGGCCGGCCGCCTGCGTTTCTCGACCGACGTCGAGGCGGCCGTCGCGCACGGCGACGTGCAGTTCATCGCGGTCGGCACGCCGCCCGACGAGGACGGCTCGGCCGATCTGCAGTACGTGCTCGCGGCCGCGCGCAACATCGGCCGCTACATGAAGGGCTTCAAGGTGATCGTCGACAAGTCGACGGTGCCGGTCGGCACGGCGGAACGCGTGCGCGCGGCGGTCGCGGAAGAGCTCGCGAAGCGCGGCGACGATTCGATGTTCTCGGTCGTGTCGAATCCGGAGTTCCTGAAGGAGGGCGCGGCGGTCGACGACTTCACGCGGCCCGACCGCATCGTGATCGGCTGCGACGACGACGTGCCGGGCGAGCGCGCGCGCGAGCTGATGAAGAAGCTGTATGCGCCGTTCAACCGCAATCACGAACGCACGCTCTACATGGACGTGCGCTCGGCCGAGTTCACGAAGTACGCGGCCAACGCGATGCTCGCGACGCGCATCTCGTTCATGAACGAGCTCGCGAACCTCGCGGACCGCTTCGGCGCCGACATCGAATCGGTGCGGCGCGGGATCGGCTCCGATCCGCGCATCGGCTATCACTTCCTCTATGCCGGCTGCGGCTACGGCGGCTCGTGCTTCCCGAAGGACGTCGAGGCGCTGATCCGCACGGCCGACGAACACGGGCACACGCTGCAGATCCTGAAGGCCGTGTCGTCGGTGAACGCCGCGCAAAAGCGCGTGCTCGCCGAGAAGATCGTCGCGCGCTTCGGCGAGGATCTGACGGGCCGCACGTTCGGCCTCTGGGGGCTCGCGTTCAAGCCGAACACCGACGACATGCGCGAGGCGCCGAGCCGCGAGCTGATCGCCGAGCTGCTGTCGCGCGGCGCGCGCGTCGCCGCGTACGACCCGGTCGCGCAGCGCGAGGCGCGCCGCGTGCTCGCGCTCGATCTCGCCGATCGTCCGGCGTGGCTCGAACGGCTCAGCTTCGTCGACGACGAGGCGCAGGCCGCGCGCGATGCCGATGCGCTCGTGATCGTCACCGAATGGAAGGCATTCAAGAGCCCCGATTTCGCGGCGCTCGGCCGGCTGTGGAAAGCACCCGTGATCTTCGACGGCCGCAACCTCTACGAGCCCGACACGATGAGCGAGCACGGCATCGAGTATCACCCGATCGGCCGTCCGGGCTCGCGGCAGGCCGTCGCCGCGCGAGCGCCCGGCGCCGCCCGCGCCAGCGCGTGA	MNLTIIGSGYVGLVTGACLADIGHDVFCLDVDQAKIDVLNDGGVPIHEPGLKEVIARNRAAGRLRFSTDVEAAVAHGDVQFIAVGTPPDEDGSADLQYVLAAARNIGRYMKGFKVIVDKSTVPVGTAERVRAAVAEELAKRGDDSMFSVVSNPEFLKEGAAVDDFTRPDRIVIGCDDDVPGERARELMKKLYAPFNRNHERTLYMDVRSAEFTKYAANAMLATRISFMNELANLADRFGADIESVRRGIGSDPRIGYHFLYAGCGYGGSCFPKDVEALIRTADEHGHTLQILKAVSSVNAAQKRVLAEKIVARFGEDLTGRTFGLWGLAFKPNTDDMREAPSRELIAELLSRGARVAAYDPVAQREARRVLALDLADRPAWLERLSFVDDEAQAARDADALVIVTEWKAFKSPDFAALGRLWKAPVIFDGRNLYEPDTMSEHGIEYHPIGRPGSRQAVAARAPGAARASA	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	121.13	gnl|BL_ORD_ID|894|hsp_num:0	842			0	1029	polymyxin B
BGC0000808.1|Cepacian_10 # 11441 # 12814 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.648	BGC0000808.1|Cepacian_10 	11441	12814	-	Loose	670	25.7942	Escherichia coli acrA	31.58	3004043	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTGAGCGTGCTGGCGAGAGTCATCGATATCGCGATGGTCGTGGCGGGAGCGCTGCTCGCCGCCGCGCTGCATCGCGGCAACGTGTGGTTCAGCGACCTGCAGCGCACGATGGTGCTGTTCGACTGCCTGCTCGTCGTCGTGTGCTTTCCCGCATTCGGCATCTATCAGTCCTGGCGCGGCAAGCGGCTCGTCGGGCTGATGGGCCGCGTCGCGTTCGCATGGCTCGTCGTCGAGCTCGCGGGCATCCTGATGAGTTTCAGCTTTCATCAGTCGGGCGAACTGTCGCGGCTCTGGCTCGGCTACTGGGCGATCGCGACGGTCACGCTGCTCGCCGGCTCGAAGGCGTGCGTGCATGCGGTGCTGCGGCGGCTGCGGCGCGGCGGCTTCAACCTGAAGGCGGTCGCGATCGTCGGCGGCACGCCGGCCGCGCGGCGGCTGATTGCGCAGATGCGCGCGCGTCCGGAAGCGGGCTTCAACCCGGTGTGCGTGTACGACGAGGACGCGGCGCCCGGCGACGTCGCGCTCGACGACGTGCGTATCGAGCGGCAGTTCGAATCGCTGGTCTGGCTCGTGCGTAGCCGCGCGATTCGCGAGCTGTGGCTGACCTTGCCGATCTCGGAAGAGCGGCGCATTCATCAGATCGTCACGGTGTTTCGTCATGACTTCGTGAACATCCGTTTCATTCCGGACGTGCGCAGCCTGTCGTTCTTCAACCAGGAAGTGGTCGAGGTGCTCGGCGTGCCGGCGATCAACCTCGCGGCGTCGCCGATCACCGACGTGCGGATCCTGCCGAAGTTCGTGTTCGACCGGATGTTCGCGCTTGCCGCGCTCGTGATGCTCGCACCGCTGATGCTCGTGATCGCGTGCCTCATCAAGGCGACCTCGCCGGGGCCCGTGTTCTTCCGGCAGAAGCGCAAGGGCATCGACGGGCACGAGTTCGAGATCTACAAGTTCCGCTCGATGAAGGTGCATCAGGAAGCGGCGGGCACGGTGACGCAGGCAACGAAGAACGACTCGCGCGTGACGCCGGTCGGCCGGTTCCTGCGCCGCACGAGCCTCGACGAACTGCCGCAGTTCATCAACGTGCTGAAGGGCGAGATGTCGGTCGTCGGTCCGCGTCCGCATGCGCTCGCGCACGACGACATCTACAAGGATTTGGTCAAGGGCTACATGTTCCGCTATCGGATCAAGCCCGGCATCACCGGCTGGGCGCAGATCAACGGCTATCGCGGCGAGACCGACCAGATCGAGAAGATGATGGGGCGCGTGAAGCTCGATCTGTACTACATGCAGAACTGGTCGTTCTGGCTCGACATCAAGATCGTCGCGCTGACGCTGTGGAAAGGCTTCACGGGCAGCAACGCGTACTGA	MLSVLARVIDIAMVVAGALLAAALHRGNVWFSDLQRTMVLFDCLLVVVCFPAFGIYQSWRGKRLVGLMGRVAFAWLVVELAGILMSFSFHQSGELSRLWLGYWAIATVTLLAGSKACVHAVLRRLRRGGFNLKAVAIVGGTPAARRLIAQMRARPEAGFNPVCVYDEDAAPGDVALDDVRIERQFESLVWLVRSRAIRELWLTLPISEERRIHQIVTVFRHDFVNIRFIPDVRSLSFFNQEVVEVLGVPAINLAASPITDVRILPKFVFDRMFALAALVMLAPLMLVIACLIKATSPGPVFFRQKRKGIDGHEFEIYKFRSMKVHQEAAGTVTQATKNDSRVTPVGRFLRRTSLDELPQFINVLKGEMSVVGPRPHALAHDDIYKDLVKGYMFRYRIKPGITGWAQINGYRGETDQIEKMMGRVKLDLYYMQNWSFWLDIKIVALTLWKGFTGSNAY	MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS	115.11	gnl|BL_ORD_ID|2321|hsp_num:0	2661			15	129	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000808.1|Cepacian_11 # 13245 # 14771 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.678	BGC0000808.1|Cepacian_11 	13245	14771	+	Loose	600	30.8018	LUS-1	33.78	3006942	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	LUS beta-lactamase	ATGAATGCCCCGACCGTGACGGCCGACACGCATGACGTCGCCGCTGCCGCCCCTGCCGTCGGCACGCGCGTCGCCGTGCAGCCGGTGATCCTTGCCGGCGGTTCCGGCACGCGCCTGTGGCCGATGTCGCGCGAACACTATCCGAAGCAGCTGATCGGCCTGCTCGGCGACCATTCGCTGCTGCAGTCCACCGCGCTGCGTCTCGACGGCCTGACGGCCGGCCATCCGCTCAACGACGACGTGCTGATCGTCTGCGGCGAAGATCATCGCTTCACGACCGCCGAACAATTGCGTCTGACCGGCAAGCGCGCGTCGATCCTGCTCGAGCCGATCGGTCGCGACACCGCGCCCGCGCTGACGCTGGCCGCGCTGAAGATCGTCGCGAGCGGCGACGATGCGGTGATGACCGTGATGCCGGCCGATCATGCGGTCGCCGATCTGCCGCGCTTTCACGCGGCCGTCGCGGCCGGTGTGCACTGCGCGGCGCAAGGCCGCATCGCGACGATGGGCATCGTGCCCGACCGCGCGGAGACGGGCTACGGCTACATCCGCGTCGGCGCGCCGCTCGGCGATGCGGGCACGGGCACCCTCGACGTGCGCCGCCTCGACCGCTTCGTCGAGAAGCCGCATCTCGAACTCGCGCAGCAGTACGTCGCGTCCGGCGAATATTGGTGGAACAGCGGGATCTTCATCGTGCGCGCGTCGGTCTGGCTGAATGCGATCCGCGAACTCGAGCCCGCGATCTATGCGGCCTGCGAGCAGGCGATCGCACAGGGTCGCGACGACGGCGACTTCTTCCGCGTCGATCGCGACGCGTTCGCCGCGTCGCCGTCGAACTCGATCGACTACGCCGTGATGGAGCCGCTCGCGAACCGGCCGTCCCTCTGCGAAAGCGTCGTCGTGCCGCTCGATGCGGGCTGGTCGGACGTCGGGTCGTGGGATGCAATCTGGCAGATCCTGCCGAAGGACGATGCGGACAACGTCGGCCGCGGCCACGTGCTGTTCGAGAATGCCGACTCGACGTTCGCGCATGCGGAAAGCCGGCTCGTCGCGTGCGTCGGCACGCACAATCTCGTCGTCGTCGAAACGCCCGACGCCGTGCTCGTCGCCGACAAGTCGCGCGTGCAGGACGTGAAGAAAATCGTCGGGCGCATCAAGGCCGAACACGGCGCGGAAGCGACCGACCACCGCAAGGTGCATCGTCCGTGGGGCCATTACGATTCGGTCGACATGGGCGAGCGCTTCCAGGTCAAGCGCATCGTCGTGAAGCCCGGCGCGCGGCTGTCGCTGCAGATGCATCATCATCGCGCCGAGCACTGGATCGTCGTGCGCGGCACCGCGCGCATCACGCGCGGCGACGAGACCTTCCTGCTGTCGGAAAACGAATCGACGTATATCCCGCTCGGCGTCTCGCATCGCCTCGAGAATCCCGGCAAGATGCCGCTCGAGCTGATCGAGGTGCAGTCGGGCGCGTACCTCGGCGAAGACGACATCGTGCGCTTCGACGATACGTACGGCCGTCAGTAA	MNAPTVTADTHDVAAAAPAVGTRVAVQPVILAGGSGTRLWPMSREHYPKQLIGLLGDHSLLQSTALRLDGLTAGHPLNDDVLIVCGEDHRFTTAEQLRLTGKRASILLEPIGRDTAPALTLAALKIVASGDDAVMTVMPADHAVADLPRFHAAVAAGVHCAAQGRIATMGIVPDRAETGYGYIRVGAPLGDAGTGTLDVRRLDRFVEKPHLELAQQYVASGEYWWNSGIFIVRASVWLNAIRELEPAIYAACEQAIAQGRDDGDFFRVDRDAFAASPSNSIDYAVMEPLANRPSLCESVVVPLDAGWSDVGSWDAIWQILPKDDADNVGRGHVLFENADSTFAHAESRLVACVGTHNLVVVETPDAVLVADKSRVQDVKKIVGRIKAEHGAEATDHRKVHRPWGHYDSVDMGERFQVKRIVVKPGARLSLQMHHHRAEHWIVVRGTARITRGDETFLLSENESTYIPLGVSHRLENPGKMPLELIEVQSGAYLGEDDIVRFDDTYGRQ	MKGFFRIKSVVCGVFLLMISVNAFAQKSELREKLQRIVNAHSATIGFSLTDLRNGDTLTVNGTKHLPMQSVYKFHLALAVLDQVDQGKLKLDQKIMVKKSDLLPDTWSPLRDKYPNGEVEIPLSEILSFTVSQSDNNGCDILFRLIGGPAKVNRYIHHLGIKDVAITATEEQMHQNDQIQFTNWTTPQAATELLGLFYAKKILSPASHEFLCKVMTETSTGADKIKGLLPAGTLAAHKTGSSGANKSGLTAASNDIGIVTLPDGKHFAVAAFVSMTKEDEKATDLIIAELTKASWDYLTTGKP	167.66	gnl|BL_ORD_ID|3683|hsp_num:0	4753			687	909	
